Stay updated with breaking news from Accessed May. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A lipoprotein (a) (Lp[a]) assay has been granted breakthrough device designation to expand identification of patients with elevated Lp(a) and genetic predispositions to cardiovascular disease.
A1901p UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ...
The FDA has granted orphan drug designation to azeliragon as a potential therapeutic option for patients with pancreatic cancer.
Professor Susan Cleary argues that the NHI is a wide-ranging reform with both positive and controversial aspects. The key will be to find a middle ground in order to continue the journey to universal health coverage.
FDA has given accelerated approval for lisocabtagene maraleucel (liso-cel; Breyanzi) for patients with relapsed or refractory (R/R) follicular lymphoma.